Company registration number 13309255 (England and Wales)
GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
BALANCE SHEET
AS AT
30 APRIL 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,640
997
Current assets
Debtors
4
94,984
35,731
Cash at bank and in hand
1,859
30,639
96,843
66,370
Creditors: amounts falling due within one year
5
(32,499)
(30,918)
Net current assets
64,344
35,452
Net assets
65,984
36,449
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
65,983
36,448
Total equity
65,984
36,449

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 3 December 2025
Dr G Stewart
Director
Company registration number 13309255 (England and Wales)
GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 2 -
1
Accounting policies
Company information

Genevieve Edwards Medical Aesthetics Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 70 Tor Bryan, Ingatestone, Essex, CM4 9HN.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% per annum on net book value
1.4
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2024
1,074
Additions
1,034
At 30 April 2025
2,108
Depreciation and impairment
At 1 May 2024
77
Depreciation charged in the year
391
At 30 April 2025
468
Carrying amount
At 30 April 2025
1,640
At 30 April 2024
997
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
71,580
-
0
Other debtors
23,404
35,731
94,984
35,731
GENEVIEVE EDWARDS MEDICAL AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 4 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
-
0
1,000
Taxation and social security
23,086
27,650
Other creditors
9,413
2,268
32,499
30,918
6
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
663
-
0
7
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Loans
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
One director
2.35
24,112
142,595
1,054
(151,573)
16,188
24,112
142,595
1,054
(151,573)
16,188

The aforementioned loan is unsecured and repayable on demand.

2025-04-302024-05-01falsefalsefalse03 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr G Stewart133092552024-05-012025-04-30133092552025-04-30133092552024-04-3013309255core:OtherPropertyPlantEquipment2025-04-3013309255core:OtherPropertyPlantEquipment2024-04-3013309255core:CurrentFinancialInstrumentscore:WithinOneYear2025-04-3013309255core:CurrentFinancialInstrumentscore:WithinOneYear2024-04-3013309255core:CurrentFinancialInstruments2025-04-3013309255core:CurrentFinancialInstruments2024-04-3013309255core:ShareCapital2025-04-3013309255core:ShareCapital2024-04-3013309255core:RetainedEarningsAccumulatedLosses2025-04-3013309255core:RetainedEarningsAccumulatedLosses2024-04-3013309255bus:Director12024-05-012025-04-3013309255core:FurnitureFittings2024-05-012025-04-30133092552023-05-012024-04-3013309255core:OtherPropertyPlantEquipment2024-04-3013309255core:OtherPropertyPlantEquipment2024-05-012025-04-3013309255bus:PrivateLimitedCompanyLtd2024-05-012025-04-3013309255bus:SmallCompaniesRegimeForAccounts2024-05-012025-04-3013309255bus:FRS1022024-05-012025-04-3013309255bus:AuditExemptWithAccountantsReport2024-05-012025-04-3013309255bus:FullAccounts2024-05-012025-04-30xbrli:purexbrli:sharesiso4217:GBP